Skip to main content
NVCR
NASDAQ Life Sciences

Japan Approves Novocure's Optune Pax for Pancreatic Cancer

Tom Rudovsky · Reported by BusinessWire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$16.06
Mkt Cap
$1.857B
52W Low
$9.82
52W High
$21.451
52W Position info
64% above low
Off High info
25% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

NVCR sits 64% above its 52-week low of $9.82.

Summary

Japan's MHLW approved Optune Pax for unresectable locally advanced pancreatic cancer, expanding the device's commercial reach into a major oncology market. The approval follows positive Phase 3 PANOVA-3 data showing statistically significant overall survival improvement. This is the third major regulatory nod for Optune Pax after FDA approval in February 2026 and CE Mark in June 2026. Japan has approximately 46,000 pancreatic cancer diagnoses annually, representing a meaningful commercial opportunity. The approval validates the therapy's clinical profile and supports further global expansion.

At the time of this announcement, NVCR was trading at $16.06 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $9.82 to $21.45. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

NVCR - Latest Insights

NVCR
Oct 29, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $14.25
Real-time Price: $13.61 info
Change: -$0.640 (-4%) info
Market Cap: $1.584B info
NVCR
Oct 29, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $15.34
Real-time Price: $13.61 info
Change: -$1.73 (-11%) info
Market Cap: $1.584B info
NVCR
Oct 29, 2026, 6:59 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.25
Real-time Price: $13.61 info
Change: -$0.640 (-4%) info
Market Cap: $1.584B info
NVCR
Sep 01, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.70
Real-time Price: $13.61 info
Change: -$4.09 (-23%) info
Market Cap: $1.584B info
NVCR
Jul 23, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.76
Real-time Price: $13.61 info
Change: -$3.15 (-19%) info
Market Cap: $1.584B info